​

Funding Round

Series B - Vial

Series B - Vial

Investment Firm

Overview

Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.

Announced Date

Nov 30, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

General Catalyst

General Catalyst

General Catalyst is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorTJ Nahigian
Participant InvestorGordon Wintrob
Participant InvestorJosh Buckley
Participant InvestorBoxGroup
Participant InvestorGeneral Catalyst

Round Details and Background

Vial raised $67000000 on 2022-11-30 in Series B

Scalable biotech advancing clinical programs with cost-effective trials and computationally designed therapeutics.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 30, 2022
Series B - Vial
13-67.0M
Nov 30, 2022
Series A - Vial
2-34.0M
Apr 15, 2021
Seed Round - Vial
1-undefined

Recent Activity

There is no recent news or activity for this profile.